The COVID-19 pandemic caused by the SARS-CoV-2 virus, which originated in Wuhan, China in 2019, spread globally resulting in millions of confirmed cases and deaths. To address this urgent need, the researchers explored the potential of natural remedies as an alternative to current existing synthetic drugs. In this study, the researchers virtually screened and docked the phytochemicals present in Ocimum basilicum against the targets of SARS-CoV-2. All the five phytocompounds (Apigenin, Xanthmicrol, Eriodictyol, Kaempferol and Luteolin) obeyed Lipinski rule of five. Among the selected ligand molecule, the ADME property of Eriodictyol was good. Further toxicity analysis revealed that there was no indication of hepatotoxicity, immunotoxicity, mutagenecity and cytotoxicity in Xanthomicrol, Eriodictyol and Kaempferol. The selected ligand molecules were subjected to Molecular Docking using AutoDockVina. Compared to other drug candidates, Eriodictyol showed better interaction against SARS-CoV-2 targets proteins COVID-19 main protease (PDB ID: 6LU7), SARS-CoV-2 RNA-dependent RNA polymerase (PDB ID:7BTF), and Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) (PDB ID:1R4L) with binding energy of -7.7, -7.2 and -8.8 Kcal/mol. Eriodictyol as a ACE-2 inhibitor, could inhibit ACE-2 by altering its structural composition or by affecting glycosylation, which prevents ACE-2 from arriving to the surface and blocking the virus's ability to enter the host cell. Overall, the study suggests that natural remedies, such as the Eriodictyol present in Ocimum basilicum, may provide a potential alternative approach to the treatment of COVID-19. Further research is needed to explore the efficacy of these compounds and their potential as therapeutic agents.